0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query sp consulting china drugs melanoma treatment market research report forecast 2017 2022.Your search for "" gave back 1533064 results.
Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family...
Catalog:
Global Markets Direct
March 2019
Price: USD 3,500.00
Cathepsin K (Cathepsin O or Cathepsin O2 or Cathepsin X or CTSK or EC 3.4.22.38) - Pipeline Review, H1 2018 Summary According to the recently...
Catalog:
Global Markets Direct
January 2018
Price: USD 3,500.00
Uveal Melanoma (Oncology) - Drugs In Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
Catalog:
Global Markets Direct
July 2021
Price: USD 2,000.00
Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T...
Catalog:
Global Markets Direct
May 2018
Price: USD 3,500.00
RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary RAF Proto...
Catalog:
Global Markets Direct
August 2018
Price: USD 3,500.00
RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) - Pipeline Review, H1 2018 Summary RAF Proto...
Catalog:
Global Markets Direct
February 2018
Price: USD 3,500.00
Acral Lentiginous Melanoma Drugs, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Melanoma drugs are medications used to treat melanoma, a type of skin cancer. They include targeted therapies, immunotherapies, and chemotherapy...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Acral Lentiginous Melanoma Drugs, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Melanoma Drugs market size was valued at US$ 2107.5 million in 2023. With growing demand in downstream market, the Melanoma Drugs is...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Toll Like Receptor 8 (CD288 or TLR8) - Pipeline Review, H2 2018 Summary Toll Like Receptor 8 (CD288 or TLR8) - Toll-like receptor 8 is a protein...
Catalog:
Global Markets Direct
November 2018
Price: USD 3,500.00
C-X-C Chemokine Receptor Type 2 - Pipeline Review, H1 2019 Summary C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity...
Catalog:
Global Markets Direct
May 2019
Price: USD 3,500.00
Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest...
Catalog:
Global Markets Direct
November 2022
Price: USD 2,500.00
Histone Deacetylase 8 - Pipeline Review, H2 2019 Summary Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) pipeline Target...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Uveal Melanoma - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Uveal...
Catalog:
Global Markets Direct
October 2018
Price: USD 2,000.00
